Drug-induced granulomatous hepatitis

Area of Science:

• Hepatology
• Immunology
• Pathology

Background:

• Granulomatous hepatitis is a histopathologic finding in 5-10% of liver biopsies.
• Tuberculosis and sarcoidosis are common causes, but other etiologies exist.
• The role of drug-induced granulomatous hepatitis is underestimated.

Purpose of the Study:

• To investigate the prevalence and characteristics of drug-induced granulomatous hepatitis.
• To differentiate drug-induced granulomas from other causes like sarcoidosis and tuberculosis.

Main Methods:

• Retrospective review of 95 granulomatous hepatitis cases from 1500 liver biopsies over 10 years.
• Analysis of histopathologic features, including eosinophil and plasma cell presence.
• Correlation with potential drug exposures.

Main Results:

• Drug-induced granulomatous hepatitis accounted for 29% of cases.
• Sarcoidosis was diagnosed in approximately one-third of cases.
• Prominent eosinophils and plasma cells suggest drug etiology, while their absence points away from tuberculosis and sarcoidosis.

Conclusions:

• Drug-induced granulomatous hepatitis is a significant and often overlooked cause of granulomatous liver disease.
• Histopathologic features, particularly eosinophil presence, can help distinguish drug-induced cases.
• Many undiagnosed or sarcoidosis-consistent cases may have a drug-induced origin.